June 2, 2015

 

Hamlet Protein to be bought by equity partners
 
 


Altor Fund IV and Goldman Sachs Merchant Banking Division will acquire the majority of Hamlet Protein from Polaris Private Equity and the founder of the company, Ole. K. Hansen.

 

Hamlet Protein is a global provider of soy-based protein solutions used in high value-add animal feed for young animals. The company services more than 50 countries from its two production facilities in Horsens, Denmark and Findlay, Ohio.

 

According to Søren Munch, CEO of Hamlet Protein, the strong support of Altor and Goldman Sachs Merchant Banking Division will uniquely position Hamlet Protein and accelerate the development and growth of the company, providing better service to its customers and partners globally.

 

"It has been a very successful partnership with Polaris, where we, along with a strong new leadership, have managed to achieve a great development for Hamlet in the recent years with a significant strengthening of Hamlet's global market position," says Hansen.

 

Søren Johansen, partner at Altor Equity Partners, adds, "We are looking forward to continuing the positive development of Hamlet Protein started by Polaris in our equal partnership with Goldman Sachs Merchant Banking Division". "We believe that Hamlet Protein is ideally positioned to become the global champion within high value-add young animal feed."

 

Managing director in the Merchant Banking Division of Goldman Sachs Michael Specht Bruun comments, "We see significant growth potential globally and are excited about partnering with Altor and the management team to support the company's impressive growth trajectory both organically and through acquisitions."

Video >

Follow Us

FacebookTwitterLinkedIn